We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYNE
7501
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1K ﹤0.01%
500
CEN
7502
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
$1K ﹤0.01%
10
+1
+11% +$83
UBP
7503
DELISTED
Urstadt Biddle Properties Inc.
UBP
$1K ﹤0.01%
34
ISEE
7504
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1K ﹤0.01%
1,058
-150
-12% -$291
VNTR
7505
DELISTED
Venator Materials PLC
VNTR
$1K ﹤0.01%
191
-11,261
-98% -$72.7K
MYOV
7506
DELISTED
Myovant Sciences Ltd.
MYOV
$1K ﹤0.01%
66
+51
+340% +$1K
FMO
7507
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$1K ﹤0.01%
+23
New +$1.2K
ADXS
7508
CALL
DELISTED
Advaxis Inc
ADXS
$1K ﹤0.01%
+427
New +$3.27K
ADXS
7509
DELISTED
Advaxis Inc
ADXS
$1K ﹤0.01%
260
-574
-69% -$4.39K
XONE
7510
PUT
DELISTED
The ExOne Company
XONE
$1K ﹤0.01%
200
-3,200
-94% -$25.8K
ZAGG
7511
PUT
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$1K ﹤0.01%
100
-8,400
-99% -$94.7K
TLI
7512
DELISTED
Western Asset Corporate Loan Fund Inc.
TLI
$1K ﹤0.01%
106
+2
+2% +$19
CHAP
7513
DELISTED
Chaparral Energy, Inc.
CHAP
$1K ﹤0.01%
+162
New +$2.06K
FGP
7514
CALL
DELISTED
Ferrellgas Partners, L.P.
FGP
$1K ﹤0.01%
1,300
-2,500
-66% -$3.5K
FTD
7515
DELISTED
FTD Companies, Inc. Common Stock
FTD
$1K ﹤0.01%
653
-761
-54% -$1.62K
AKAO
7516
PUT
DELISTED
Achaogen Inc
AKAO
$1K ﹤0.01%
700
-23,700
-97% -$63.3K
GZT
7517
DELISTED
Gazit-globe Ltd
GZT
$1K ﹤0.01%
74
-10,026
-99% -$81.7K
PAF
7518
DELISTED
Invesco FTSE RAFI Asia Pacific ex-Japan ETF
PAF
$1K ﹤0.01%
30
CYTR
7519
DELISTED
CytRx Corp
CYTR
$1K ﹤0.01%
2,135
+1,000
+88% +$690
CHIM
7520
DELISTED
Global X MSCI China Materials ETF
CHIM
$1K ﹤0.01%
51
YELL
7521
PUT
DELISTED
Yellow Corporation Common Stock
YELL
$1K ﹤0.01%
+200
New +$1.27K
MCF
7522
DELISTED
Contango Oil & Gas Co.
MCF
$1K ﹤0.01%
300
VVUS
7523
CALL
DELISTED
Vivus Inc
VVUS
$1K ﹤0.01%
400
-860
-68% -$2.96K
SDR
7524
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$1K ﹤0.01%
1,000
TIO
7525
DELISTED
Tingo Group, Inc. Common Stock
TIO
$1K ﹤0.01%
1,000

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.